← 產業報告目錄

Refurbished Medical Equipment Market by Product (Imaging (MRI, CT), Patient Monitor, Defibrillator, Dialysis, Lithotripsy, Ventilator, Incubators, Operating & Surgical Equipment), Application (CVS, Cancer, Ob/Gyn), Enduser - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-01-10頁數 412報告編號 MD3122

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The Refurbished medical equipment market is projected to reach USD 24.41 Billion by 2029 from USD 16.93 in 2024, growing at a CAGR of 7.6% during the forecast period. The market is growing due to numerous factors.Increasing cases of infectious diseases, and regular advancements in Refurbished medical equipment drives this market. Rising expenditure in research and development and increase in application of biomarker profiling to detect diseases are other factors. Additionally, the market growth is affected by inclusion of Refurbished medical equipment with artificial intelligence. “Medical imaging equipment to account for largest market share in 2023.” A market is being formed for the refurbished medical imaging equipment owing to the increased sectored investments in private healthcare and emerging health infrastructures in developing economies. This makes refurbished systems like CT and X-ray machines affordable for new hospitals within emerging markets. Multi-dimensional forces such as economic elements, technological advancement, and regulatory frameworks encourage the growth of refurbished medical imaging equipment markets globally. Organizations dealing in refurbished medical imaging adhere to many regulations since these should guarantee that they meet or exceed the industry standards. Siemens Healthineers and GE Healthcare, for instance, provides refurbished MRI systems and CT scanners with warranties and certifications. “Hospitals to hold largest share in the market.” Various significant factors are propelling the growth of hospitals in the refurbished medical equipment industry. Numerous causes like economic pressures, technological advancements, and healthcare-related factors have encouraged the global growth of refurbished medical equipment in hospitals and surgical centers. Some of these causes include rising prices for new medical devices, the increasing requirement for cost-effective health-care solutions, and improvements in refurbishment methods. A good example of commonly utilized ultrasound windows is in rural areas or areas with low budgets. They provide high performance while being cheaper than new equipment; thus, they ensure diagnostic services continue even at low-resource settings. "North America to register largest share in 2023." The largest share was hold by North America in 2023. North America comprise US and Canada. Reduced costs are one of the most major factors attracting North America towards refurbished medical equipment. Genuinely refurbished equipment serves as a shake quality alternative to new devices, enabling hospitals to make do even with very restricted budgets. Above all, pressure from the government for sustainability and the reduction of electronic waste in North America adds importance to refurbishing medical equipment. It promises to nullify the environmental impact of thrown-up devices and at the same time promote circular economies. In North America, refurbished medical equipment stands under very stringent regulatory requirements (like FDA in the U.S.). The quality and safety assured make healthcare providers much more confident in purchasing refurbished devices. As well, hospitals and clinics grow their medical arms without making huge financial outlays for the refurbished option to fulfill the high demand for urine ultrasound machines in North America. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3– 20% • By Designation: C-level-- 35%, Director-level–25%, and Others–40% • By Region: North America–40%, Europe-30%, Asia Pacific–20%, Latin America - 5%, Middle East & Africa- 5% Prominent players in the Refurbished medical equipment market include GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Block Imaging International,Inc. (US), Canon Medical Systems Corp. (Japan), Soma Technology, Inc. (US), and Avante Health Solutions (US), Mindray Medical International (China), Dragerwerk AG & Co. KGAA (Germany), Whittemore Enterprises (U.S.), Stryker (US), Directmed Parts & Services (US), Medline Industries (U.S.), Traco Medical (U.S.), Nihon Kohden Corporation (Japan), Master Medical Equipment (U.S.), and Everx Pvt. Ltd. (US). Research Coverage The report comprise segmentation that includes end users, products, applications, and geographic regions. It also discusses the key drivers, restraints, opportunities, and challenges affecting the growth of the Refurbished medical equipment market. The research offers stakeholders an assessment of market potential and challenges, with a focus on key players and competitive landscapes. Additionally, micromarkets are assessed according to their overall to the refurbished medical equipment sector, growth patterns, and potential. The analysis estimates increase in market segment revenues, focusing on five regions. Key Benefits of Buying the Report: This research aids new and existing players in the Refurbished medical equipment market to assess the sustainability of their investments by offering detailed information. It offers a dataset to assist in making key decisions. The main advantage of this report includes risk evaluation and offering direction for investment decisions. Market segmentation as per the end-users and geographical areas is offered in the study, that provides analysis and insights. It also provides trends, obstacles, opportunities, and drivers, giving stakeholders the information they need to make strategic decisions. The report provides the insights on the following pointers: Analysis of the key drivers, restraints, opportunities, and challenges impacting the Refurbished medical equipment market growth: rise in prevalence of chronic diseases, cost efficiency as compared to new medical equipment; negative perception for refurbished product quality; updated technology with software integration and regulatory support helps refurbished medical equipment to grow in the market. Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the refurbished medical equipment industry. Market Development: Details related to profitable markets: this research discussees the Refurbished medical equipment business in numerous regions. Market Diversification: Detailed understanding of advanced products, unexplored areas, latest developments, and investment in the market. Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Avante Health Solutions (US), Soma Technology, Inc. (US) and Canon Medical Systems Coproration(Japan).
目錄 Table of Contents
1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.3 STUDY SCOPE 35 1.3.1 SEGMENTS COVERED & GEOGRAPHICAL SPREAD 35 1.3.2 INCLUSIONS & EXCLUSIONS 36 1.3.3 YEARS CONSIDERED 37 1.3.4 CURRENCY CONSIDERED 37 1.4 MARKET STAKEHOLDERS 38 1.5 SUMMARY OF CHANGES 38 2 RESEARCH METHODOLOGY 39 2.1 RESEARCH DATA 39 2.2 RESEARCH DESIGN 40 2.2.1 SECONDARY RESEARCH 40 2.2.1.1 Key secondary sources 40 2.2.1.2 Key objectives of secondary research 41 2.2.1.3 Key data from secondary sources 42 2.2.2 PRIMARY RESEARCH 42 2.2.2.1 Key primary sources 43 2.2.2.2 Key objectives of primary research 43 2.2.2.3 Key industry insights 44 2.2.2.4 Breakdown of primaries 44 2.3 MARKET SIZE ESTIMATION 45 2.3.1 BOTTOM-UP APPROACH 46 2.3.1.1 Company revenue estimation approach 47 2.3.1.2 Customer-based market estimation 47 2.3.2 TOP-DOWN APPROACH 48 2.3.2.1 Primary interviews 49 2.4 MARKET GROWTH FORECAST 49 2.5 DATA TRIANGULATION 50 2.6 MARKET SHARE ASSESSMENT 51 2.7 STUDY ASSUMPTIONS 51 2.8 GROWTH ASSUMPTIONS 51 2.9 RISK ASSESSMENT 53 2.10 RESEARCH LIMITATIONS 54 3 EXECUTIVE SUMMARY 55 4 PREMIUM INSIGHTS 60 4.1 REFURBISHED MEDICAL EQUIPMENT MARKET OVERVIEW 60 4.2 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 61 4.3 REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY AND END USER, 2023 (USD MILLION) 62 4.4 GEOGRAPHIC SNAPSHOT OF REFURBISHED MEDICAL EQUIPMENT MARKET 63 5 MARKET OVERVIEW 64 5.1 INTRODUCTION 64 5.2 MARKET DYNAMICS 64 5.2.1 DRIVERS 65 5.2.1.1 Increased need for affordable and advanced diagnostic imaging equipment 65 5.2.1.2 Better warranties and service agreements for refurbished equipment 65 5.2.1.3 Increased focus on environmental sustainability in healthcare sector 66 5.2.1.4 Rising healthcare costs and need for cost-saving alternatives 66 5.2.2 RESTRAINTS 67 5.2.2.1 Lesser reliability in high-regulated sectors and lack of standardized refurbishment processes 67 5.2.2.2 Availability of cost-effective new medical equipment 67 5.2.3 OPPORTUNITIES 68 5.2.3.1 Increased acceptability of refurbished equipment by large hospitals and healthcare systems 68 5.2.3.2 Expansion of online marketplaces and global logistics networks 68 5.2.4 CHALLENGES 69 5.2.4.1 Lack of uniform refurbishment standards for medical equipment 69 5.2.4.2 Rapid innovation in medical technology 69 5.3 VALUE CHAIN ANALYSIS 70 5.4 PORTER’S FIVE FORCES ANALYSIS 72 5.4.1 THREAT OF NEW ENTRANTS 73 5.4.2 THREAT OF SUBSTITUTES 73 5.4.3 BARGAINING POWER OF SUPPLIERS 73 5.4.4 BARGAINING POWER OF BUYERS 73 5.4.5 INTENSITY OF COMPETITIVE RIVALRY 74 5.5 KEY STAKEHOLDERS & BUYING CRITERIA 74 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 74 5.5.2 KEY BUYING CRITERIA 75 5.6 PATENT ANALYSIS 76 5.6.1 LIST OF MAJOR PATENTS 77 5.7 KEY CONFERENCES & EVENTS, 2024–2026 79 5.8 TRADE DATA ANALYSIS 80 5.8.1 IMPORT DATA FOR HS CODE 9018 80 5.8.2 EXPORT DATA FOR HS CODE 9018 81 5.9 PRICING ANALYSIS 81 5.9.1 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL EQUIPMENT, BY REGION, 2021–2023 81 5.9.2 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL IMAGING EQUIPMENT, BY PRODUCT, 2021–2023 85 5.9.3 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT, BY KEY PLAYER, 2023 88 5.10 UNMET NEEDS & KEY PAIN POINTS 89 5.11 ECOSYSTEM ANALYSIS 90 5.12 SUPPLY CHAIN ANALYSIS 91 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93 5.14 TECHNOLOGY ANALYSIS 93 5.14.1 KEY TECHNOLOGIES 93 5.14.1.1 Portable and point-of-care medical devices 93 5.14.1.2 Diagnostic imaging systems 94 5.14.1.3 Laboratory, surgical, and therapeutic equipment 94 5.14.2 COMPLEMENTARY TECHNOLOGIES 94 5.14.2.1 AI-powered predictive analytics 94 5.14.2.2 Digital connectivity and telemedicine technologies 95 5.14.2.3 Remote monitoring technologies 95 5.14.3 ADJACENT TECHNOLOGIES 95 5.14.3.1 Robotics and automation technologies 95 5.15 REGULATORY LANDSCAPE 96 5.15.1 REGULATORY FRAMEWORK 96 5.15.1.1 North America 96 5.15.1.1.1 US 96 5.15.1.1.2 Canada 96 5.15.2 EUROPE 97 5.15.3 ASIA PACIFIC 98 5.15.3.1 Japan 98 5.15.3.2 China 99 5.15.3.3 India 99 5.15.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 5.16 INVESTMENT & FUNDING SCENARIO 102 5.17 REIMBURSEMENT SCENARIO ANALYSIS 104 5.18 IMPACT OF AI/GEN AI ON REFURBISHED MEDICAL EQUIPMENT MARKET 105 6 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT 106 6.1 INTRODUCTION 107 6.2 MEDICAL IMAGING EQUIPMENT 108 6.2.1 CT SCANNERS 113 6.2.1.1 Cost-effectiveness and favorable government regulations to propel segment growth 113 6.2.2 MRI MACHINES 116 6.2.2.1 Need to reduce healthcare costs and increase focus on technological advancements to aid market growth 116 6.2.3 X-RAY MACHINES 119 6.2.3.1 Availability of flexible leasing and financing options to spur adoption 119 6.2.4 NUCLEAR IMAGING SYSTEMS 122 6.2.4.1 Public-private investments for purchasing new high-end nuclear imaging systems to limit market growth 122 6.2.5 ULTRASOUND SYSTEMS 125 6.2.5.1 Economic downturn and decreased reimbursement for new equipment in developed countries to drive market 125 6.2.6 PET/SPECT SYSTEMS 128 6.2.6.1 Reduced electronic wastage to support sustainability initiatives in healthcare 128 6.2.7 MAMMOGRAPHY SYSTEMS 131 6.2.7.1 Rising number of breast cancer cases and decreasing cost of refurbished mammography systems to augment market growth 131 6.3 OPERATING ROOM & SURGICAL EQUIPMENT 135 6.3.1 ANESTHESIA MACHINES 139 6.3.1.1 Long waiting times for new equipment delivery to support segment growth 139 6.3.2 ELECTROSURGICAL UNITS 141 6.3.2.1 Hospital budget limitations and focus on minimally invasive surgeries to promote segment growth 141 6.3.3 OPERATING ROOM TABLES & LIGHTS 144 6.3.3.1 Low financial capabilities of healthcare organizations in emerging economies to boost adoption 144 6.3.4 SURGICAL DISPLAYS 147 6.3.4.1 High fluctuation in raw material and display panel pricing to propel adoption in healthcare settings 147 6.3.5 OTHER OPERATING ROOM & SURGICAL EQUIPMENT 151 6.4 PATIENT MONITORS 154 6.4.1 MULTIPARAMETER MONITORS 159 6.4.1.1 Increased use of home patient monitoring and low prices compared to mid- and high-acuity monitors to drive segment 159 6.4.2 FETAL MONITORS 162 6.4.2.1 Increasing prevalence of obstetric complications and preterm births to fuel adoption 162 6.4.3 ELECTROCARDIOGRAPHY DEVICES 166 6.4.3.1 Wide applications of ECG devices in cardiovascular diseases to drive market 166 6.4.4 PULSE OXIMETERS 169 6.4.4.1 Introduction of low-cost single-use pulse oximeters to limit market growth 169 6.4.5 CARDIAC MONITORS 173 6.4.5.1 Need to reduce healthcare costs and high demand for home monitoring to support market growth 173   6.4.6 NON-INVASIVE BLOOD PRESSURE MONITORS 176 6.4.6.1 Growing health awareness and increasing incidence of cardiovascular diseases to propel segment growth 176 6.4.7 OTHER PATIENT MONITORS 179 6.5 CARDIOLOGY EQUIPMENT 183 6.5.1 DEFIBRILLATORS 187 6.5.1.1 Increasing prevalence of CVDs in low-income countries to drive adoption of refurbished defibrillators 187 6.5.2 HEART-LUNG MACHINES 190 6.5.2.1 Rising number of cardiac surgeries to support segment growth 190 6.5.3 OTHER CARDIOLOGY EQUIPMENT 193 6.6 UROLOGY EQUIPMENT 197 6.6.1 DIALYSIS MACHINES 200 6.6.1.1 Development of low-cost dialysis products to limit market growth 200 6.6.2 LITHOTRIPSY DEVICES 203 6.6.2.1 Increasing cases of kidney and ureteric stones to increase demand for refurbished lithotripsy devices 203 6.7 NEUROLOGY EQUIPMENT 206 6.7.1 EMG MACHINES 211 6.7.1.1 Use of EMG nerve monitoring for intraoperative applications to fuel segment growth 211 6.7.2 EEG MACHINES 213 6.7.2.1 Reimbursement cuts to increase adoption of refurbished EEG machines 213 6.8 INTENSIVE CARE EQUIPMENT 216 6.8.1 VENTILATORS 221 6.8.1.1 Improved refurbishment techniques for upgrading used ventilators to drive growth 221 6.8.2 INFANT INCUBATORS & WARMERS 224 6.8.2.1 High global birthrate and increasing number of neonates requiring additional medical intervention to fuel segment growth 224 6.9 INTRAVENOUS THERAPY SYSTEMS 228 6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND FREQUENT PRODUCT RECALLS TO SUPPORT MARKET GROWTH 228 6.10 ENDOSCOPY EQUIPMENT 232 6.10.1 RISING DEMAND FOR ENDOSCOPY IN DETECTING CHRONIC DISEASES TO SUPPORT MARKET GROWTH 232 6.11 OTHER MEDICAL EQUIPMENT 236 7 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION 241 7.1 INTRODUCTION 242 7.2 CARDIOLOGY DIAGNOSTIC APPLICATIONS 244 7.2.1 INCREASING INCIDENCE OF CARDIOVASCULAR AND CARDIO-PULMONARY DISORDERS TO DRIVE MARKET 244   7.3 UROLOGY DIAGNOSTIC APPLICATIONS 245 7.3.1 LOW BUDGET AVAILABILITY FOR PROCURING NEW UROLOGICAL EQUIPMENT TO AID MARKET GROWTH 245 7.4 NEUROLOGY DIAGNOSTIC APPLICATIONS 246 7.4.1 BUDGET CONSTRAINTS TO INCREASE DEMAND FOR REFURBISHED MEDICAL EQUIPMENT AND STRATEGIC RESOURCE ALLOCATION 246 7.5 ORTHOPEDIC DIAGNOSTIC APPLICATIONS 247 7.5.1 GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF TARGET DISEASES TO AID MARKET GROWTH 247 7.6 PHYSIOLOGY DIAGNOSTIC APPLICATIONS 248 7.6.1 RISING AWARENESS OF EARLY DISEASE DIAGNOSIS AND GROWING FOCUS ON HEALTHY LIFESTYLES TO AUGMENT MARKET GROWTH 248 7.7 EMERGENCY MEDICINE DIAGNOSTIC APPLICATIONS 249 7.7.1 INCREASING NUMBER OF NEONATES IN INTENSIVE CARE UNITS TO PROPEL MARKET GROWTH 249 7.8 ONCOLOGY DIAGNOSTIC APPLICATIONS 250 7.8.1 HIGH INCIDENCE OF MALIGNANCIES AND INCREASED COST OF NEW MEDICAL IMAGING EQUIPMENT TO FUEL MARKET GROWTH 250 7.9 OB/GYNECOLOGY DIAGNOSTIC APPLICATIONS 251 7.9.1 INCREASING NUMBER OF MATERNITY CENTERS AND DIAGNOSTIC CLINICS TO SUPPORT MARKET GROWTH 251 7.10 OTHER DIAGNOSTIC APPLICATIONS 251 7.11 CARDIOLOGY THERAPEUTIC APPLICATIONS 252 7.11.1 LOW COST OF REFURBISHED EQUIPMENT AND HIGH-QUALITY CONTROL MEASURES BY OEMS TO DRIVE MARKET 252 7.12 UROLOGY THERAPEUTIC APPLICATIONS 253 7.12.1 BUDGETARY CONSTRAINTS IN PROCURING NEW EQUIPMENT TO BOOST MARKET GROWTH 253 7.13 NEUROLOGY THERAPEUTIC APPLICATIONS 254 7.13.1 GROWING DEMAND FOR REFURBISHED ELECTROSURGERY AND SURGICAL EQUIPMENT TO PROPEL MARKET GROWTH 254 7.14 ORTHOPEDIC THERAPEUTIC APPLICATIONS 255 7.14.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET 255 7.15 PHYSIOLOGY THERAPEUTIC APPLICATIONS 256 7.15.1 DEARTH OF SKILLED SPECIALISTS IN EMERGING ECONOMIES TO LIMIT MARKET GROWTH 256 7.16 EMERGENCY MEDICINE THERAPEUTIC APPLICATIONS 257 7.16.1 IMPROVED CRITICAL CARE INFRASTRUCTURE AND NEED FOR MORE ESSENTIAL CARE EQUIPMENT TO AUGMENT MARKET GROWTH 257 7.17 ONCOLOGY THERAPEUTIC APPLICATIONS 258 7.17.1 GROWING NUMBER OF NON-INVASIVE AND INTERVENTIONAL CANCER TREATMENT PROCEDURES TO AID MARKET SEGMENT 258 7.18 OB/GYNECOLOGY THERAPEUTIC APPLICATIONS 259 7.18.1 GROWING AWARENESS OF MATERNITY CARE IN EMERGING ECONOMIES TO DRIVE MARKET GROWTH 259 7.19 OTHER THERAPEUTIC APPLICATIONS 260 8 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER 261 8.1 INTRODUCTION 262 8.2 HOSPITALS 262 8.2.1 REFURBISHED EQUIPMENT TO IMPROVE HEALTHCARE INFRASTRUCTURE WITHOUT HIGH COST OF NEW DEVICES 262 8.3 DIAGNOSTIC IMAGING CENTERS 263 8.3.1 INCREASED NEED FOR IMAGING FOR EARLY DETECTION AND TREATMENT PLANNING TO SPUR MARKET GROWTH 263 8.4 ACADEMIC & GOVERNMENT ORGANIZATIONS 264 8.4.1 REFURBISHED EQUIPMENT TO OFFER FINANCIALLY VIABLE ALTERNATIVE AND REDUCE ELECTRONIC WASTAGE 264 8.5 AMBULATORY CARE CENTERS 265 8.5.1 INCREASING PREFERENCE FOR OUTPATIENT PROCEDURES TO PROPEL MARKET GROWTH 265 8.6 OTHER END USERS 266 9 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION 268 9.1 INTRODUCTION 269 9.2 NORTH AMERICA 269 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 270 9.2.2 US 274 9.2.2.1 US to dominate refurbished medical equipment market during forecast period 274 9.2.3 CANADA 276 9.2.3.1 Budgetary constraints in hospitals and high demand for imaging procedures to aid adoption of refurbished medical equipment 276 9.3 EUROPE 277 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 278 9.3.2 GERMANY 282 9.3.2.1 Well-established pharmaceutical and R&D industry to propel market growth 282 9.3.3 FRANCE 284 9.3.3.1 Increasing government pressure to reduce healthcare costs to support market growth 284 9.3.4 UK 285 9.3.4.1 Rising preference for new equipment due to better safety and compliance to limit market 285 9.3.5 ITALY 287 9.3.5.1 Supportive government policies and focus on value-based healthcare system to boost market growth 287 9.3.6 SPAIN 288 9.3.6.1 Technological advancements and improved healthcare infrastructure to aid market growth 288 9.3.7 REST OF EUROPE 290   9.4 ASIA PACIFIC 291 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 291 9.4.2 CHINA 297 9.4.2.1 Rapidly changing healthcare infrastructure and favorable government incentives to fuel market growth 297 9.4.3 JAPAN 299 9.4.3.1 High geriatric population and favorable health insurance system to propel market growth 299 9.4.4 INDIA 300 9.4.4.1 Low cost of refurbished equipment and need for alternatives to healthcare service to support market growth 300 9.4.5 AUSTRALIA 302 9.4.5.1 Preference for new equipment by government healthcare organizations to limit demand for refurbished medical equipment 302 9.4.6 SOUTH KOREA 303 9.4.6.1 Increased insurance coverage and free trade agreements with US to support market growth 303 9.4.7 REST OF ASIA PACIFIC 305 9.5 LATIN AMERICA 305 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 306 9.5.2 BRAZIL 309 9.5.2.1 Growing disease burden and rising awareness about advanced diagnostic and treatment procedures to support market growth 309 9.5.3 MEXICO 311 9.5.3.1 Favorable investment scenario for refurbished medical device manufacturers to drive market 311 9.5.4 REST OF LATIN AMERICA 312 9.6 MIDDLE EAST & AFRICA 313 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 314 9.6.2 GCC COUNTRIES 317 9.6.2.1 Advancements in healthcare infrastructure and increased focus on personalized medicines to fuel market growth 317 9.6.3 REST OF MIDDLE EAST & AFRICA 318 10 COMPETITIVE LANDSCAPE 320 10.1 INTRODUCTION 320 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 320 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REFURBISHED MEDICAL EQUIPMENT MARKET 320 10.3 REVENUE ANALYSIS, 2019–2023 322 10.4 MARKET SHARE ANALYSIS, 2023 323 10.4.1 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023 323   10.4.2 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023 323 10.4.3 REFURBISHED PATIENT MONITORS MARKET SHARE, BY KEY PLAYER, 2023 324 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 326 10.5.1 STARS 326 10.5.2 EMERGING LEADERS 326 10.5.3 PERVASIVE PLAYERS 326 10.5.4 PARTICIPANTS 326 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 328 10.5.5.1 Company footprint 328 10.5.5.2 Region footprint 329 10.5.5.3 Product footprint 330 10.5.5.4 Application footprint 331 10.5.5.5 End-user footprint 332 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 333 10.6.1 PROGRESSIVE COMPANIES 333 10.6.2 RESPONSIVE COMPANIES 333 10.6.3 DYNAMIC COMPANIES 333 10.6.4 STARTING BLOCKS 333 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023 335 10.7 COMPANY VALUATION & FINANCIAL METRICS 337 10.8 PRODUCT/BRAND COMPARISON 338 10.9 COMPETITIVE SCENARIO 339 10.9.1 PRODUCT LAUNCHES 339 10.9.2 DEALS 340 11 COMPANY PROFILES 341 11.1 KEY PLAYERS 341 11.1.1 GE HEALTHCARE 341 11.1.1.1 Business overview 341 11.1.1.2 Products offered 343 11.1.1.3 Recent developments 345 11.1.1.3.1 Product launches 345 11.1.1.3.2 Deals 345 11.1.1.3.3 Expansions 345 11.1.1.4 MnM view 346 11.1.1.4.1 Key strengths 346 11.1.1.4.2 Strategic choices 346 11.1.1.4.3 Weaknesses & competitive threats 346 11.1.2 PHILIPS HEALTHCARE 347 11.1.2.1 Business overview 347 11.1.2.2 Products offered 348 11.1.2.3 Recent developments 350 11.1.2.3.1 Product launches 350 11.1.2.3.2 Deals 351 11.1.2.3.3 Other developments 351 11.1.2.4 MnM view 351 11.1.2.4.1 Key strengths 351 11.1.2.4.2 Strategic choices 352 11.1.2.4.3 Weaknesses & competitive threats 352 11.1.3 SIEMENS HEALTHINEERS AG 353 11.1.3.1 Business overview 353 11.1.3.2 Products offered 354 11.1.3.3 Recent developments 356 11.1.3.3.1 Deals 356 11.1.3.4 MnM view 356 11.1.3.4.1 Key strengths 356 11.1.3.4.2 Strategic choices 356 11.1.3.4.3 Weaknesses & competitive threats 356 11.1.4 STRYKER 357 11.1.4.1 Business overview 357 11.1.4.2 Products offered 358 11.1.4.3 MnM view 359 11.1.4.3.1 Key strengths 359 11.1.4.3.2 Strategic choices 359 11.1.4.3.3 Weaknesses & competitive threats 359 11.1.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 360 11.1.5.1 Business overview 360 11.1.5.2 Products offered 361 11.1.5.3 Recent developments 361 11.1.5.3.1 Product launches 361 11.1.5.4 MnM view 361 11.1.5.4.1 Key strengths 361 11.1.5.4.2 Strategic choices 362 11.1.5.4.3 Weaknesses & competitive threats 362 11.1.6 CANON MEDICAL SYSTEMS CORPORATION 363 11.1.6.1 Business overview 363 11.1.6.2 Products offered 365 11.1.6.3 Recent developments 365 11.1.6.3.1 Product launches 365 11.1.6.3.2 Deals 365 11.1.7 DRÄGERWERK AG & CO. KGAA 366 11.1.7.1 Business overview 366 11.1.7.2 Products offered 367 11.1.8 NIHON KOHDEN CORPORATION 368 11.1.8.1 Business overview 368 11.1.8.2 Products offered 369 11.1.8.3 Recent developments 370 11.1.8.3.1 Deals 370 11.1.9 OLYMPUS CORPORATION 371 11.1.9.1 Business overview 371 11.1.9.2 Products offered 373 11.1.10 AVANTE HEALTH SOLUTIONS 374 11.1.10.1 Business overview 374 11.1.10.2 Products offered 375 11.1.11 SOMA TECH INTL. 376 11.1.11.1 Business overview 376 11.1.11.2 Products offered 376 11.1.12 EVERX 378 11.1.12.1 Business overview 378 11.1.12.2 Products offered 378 11.1.13 RADIOLOGY ONCOLOGY SYSTEMS 379 11.1.13.1 Business overview 379 11.1.13.2 Products offered 379 11.1.13.3 Recent developments 380 11.1.13.3.1 Deals 380 11.1.14 MASTER MEDICAL EQUIPMENT 381 11.1.14.1 Business overview 381 11.1.14.2 Products offered 381 11.1.15 FAIR-MEDICAL INC. 382 11.1.15.1 Business overview 382 11.1.15.2 Products offered 382 11.1.16 FUTURE HEALTH CONCEPTS 383 11.1.16.1 Business overview 383 11.1.16.2 Products offered 383 11.1.17 HILDITCH GROUP LTD. 384 11.1.17.1 Business overview 384 11.1.17.2 Products offered 385 11.1.18 BLOCK IMAGING, INC. 386 11.1.18.1 Business overview 386 11.1.18.2 Products offered 386 11.1.18.3 Recent developments 387 11.1.18.3.1 Deals 387   11.2 OTHER PLAYERS 388 11.2.1 NATIONWIDE IMAGING SERVICES 388 11.2.2 PACIFIC HEALTHCARE IMAGING 389 11.2.3 VENTURE MEDICAL REQUIP 390 11.2.4 DESERT TECH MEDICAL SYSTEMS INC. 391 11.2.5 HI-TECH INTERNATIONAL 392 11.2.6 AMBER DIAGNOSTICS 393 11.2.7 WHITTEMORE ENTERPRISES 394 11.2.8 TRACO MEDICAL INC. 395 11.2.9 US MED-EQUIP 396 11.2.10 US MEDICAL SYSTEMS 397 11.2.11 MEDLINE INDUSTRIES, INC. 398 11.2.12 DIRECTMED IMAGING 399 11.2.13 AGITO MEDICAL 400 12 APPENDIX 401 12.1 DISCUSSION GUIDE 401 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 407 12.3 CUSTOMIZATION OPTIONS 409 12.4 RELATED REPORTS 410 12.5 AUTHOR DETAILS 411
圖表清單 List of Tables & Figures
TABLE 1 REFURBISHED MEDICAL EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS 36 TABLE 2 REFURBISHED MEDICAL EQUIPMENT MARKET: STUDY ASSUMPTIONS 51 TABLE 3 REFURBISHED MEDICAL EQUIPMENT MARKET: RISK ASSESSMENT 53 TABLE 4 COMPARATIVE ANALYSIS OF AVERAGE SELLING PRICE OF NEW AND REFURBISHED MEDICAL EQUIPMENT 65 TABLE 5 REFURBISHED MEDICAL EQUIPMENT MARKET: PORTER’S FIVE FORCES 73 TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 74 TABLE 7 REFURBISHED MEDICAL EQUIPMENT MARKET: LIST OF MAJOR PATENTS, 2022–2024 77 TABLE 8 REFURBISHED MEDICAL EQUIPMENT MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2026 79 TABLE 9 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2023 (USD THOUSAND) 80 TABLE 10 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019−2023 (USD THOUSAND) 81 TABLE 11 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL EQUIPMENT, BY REGION, 2021–2023 (USD) 83 TABLE 12 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT, BY KEY PLAYER, 2023 (USD) 88 TABLE 13 REFURBISHED MEDICAL EQUIPMENT MARKET: CURRENT UNMET NEEDS & KEY PAIN POINTS 89 TABLE 14 REFURBISHED MEDICAL EQUIPMENT MARKET: ROLE IN ECOSYSTEM 91 TABLE 15 US: CLASSIFICATION OF REFURBISHED MEDICAL TECHNOLOGY-ASSOCIATED MEDICAL DEVICES 96 TABLE 16 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 97 TABLE 17 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 97 TABLE 18 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 98 TABLE 19 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 99 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 25 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES, 2023 104 TABLE 26 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 107 TABLE 27 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 109 TABLE 28 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 109 TABLE 29 NORTH AMERICA: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110 TABLE 30 EUROPE: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110 TABLE 31 ASIA PACIFIC: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029(USD MILLION) 111 TABLE 32 LATIN AMERICA: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 33 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 112 TABLE 34 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 112 TABLE 35 REFURBISHED CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION) 113 TABLE 36 NORTH AMERICA: REFURBISHED CT SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 37 EUROPE: REFURBISHED CT SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 38 ASIA PACIFIC: REFURBISHED CT SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 39 LATIN AMERICA: REFURBISHED CT SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 40 MIDDLE EAST & AFRICA: REFURBISHED CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION) 116 TABLE 41 REFURBISHED MRI MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 117 TABLE 42 NORTH AMERICA: REFURBISHED MRI MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117 TABLE 43 EUROPE: REFURBISHED MRI MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118 TABLE 44 ASIA PACIFIC: REFURBISHED MRI MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118 TABLE 45 LATIN AMERICA: REFURBISHED MRI MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119 TABLE 46 MIDDLE EAST & AFRICA: REFURBISHED MRI MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 119 TABLE 47 REFURBISHED X-RAY MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 120 TABLE 48 NORTH AMERICA: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 49 EUROPE: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 50 ASIA PACIFIC: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 51 LATIN AMERICA: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122 TABLE 52 MIDDLE EAST & AFRICA: REFURBISHED X-RAY MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 122 TABLE 53 REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 123 TABLE 54 NORTH AMERICA: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123 TABLE 55 EUROPE: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 56 ASIA PACIFIC: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 57 LATIN AMERICA: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125 TABLE 58 MIDDLE EAST & AFRICA: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 125 TABLE 59 REFURBISHED ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 126 TABLE 60 NORTH AMERICA: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 61 EUROPE: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 62 ASIA PACIFIC: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 63 LATIN AMERICA: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 64 MIDDLE EAST & AFRICA: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 128 TABLE 65 REFURBISHED PET/SPECT SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 129 TABLE 66 NORTH AMERICA: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 67 EUROPE: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 68 ASIA PACIFIC: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 69 LATIN AMERICA: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131 TABLE 70 MIDDLE EAST & AFRICA: REFURBISHED PET/SPECT SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 131 TABLE 71 REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 132 TABLE 72 NORTH AMERICA: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 73 EUROPE: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133 TABLE 74 ASIA PACIFIC: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133 TABLE 75 LATIN AMERICA: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134 TABLE 76 MIDDLE EAST & AFRICA: REFURBISHED MAMMOGRAPHY SYETMS MARKET, BY REGION, 2022–2029 (USD MILLION) 134 TABLE 77 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 135 TABLE 78 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 135 TABLE 79 NORTH AMERICA: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 80 EUROPE: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 81 ASIA PACIFIC: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 82 LATIN AMERICA: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 83 MIDDLE EAST & AFRICA: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 138 TABLE 84 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 138 TABLE 85 REFURBISHED ANESTHESIA MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 139 TABLE 86 NORTH AMERICA: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 87 EUROPE: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140 TABLE 88 ASIA PACIFIC: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140 TABLE 89 LATIN AMERICA: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141 TABLE 90 MIDDLE EAST & AFRICA: REFURBISHED ANESTHESIA MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 141 TABLE 91 REFURBISHED ELECTROSURGICAL UNITS MARKET, BY REGION, 2022–2029 (USD MILLION) 142 TABLE 92 NORTH AMERICA: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 93 EUROPE: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 94 ASIA PACIFIC: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 95 LATIN AMERICA: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 96 MIDDLE EAST & AFRICA: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY REGION, 2022–2029 (USD MILLION) 144 TABLE 97 REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY REGION, 2022–2029 (USD MILLION) 145 TABLE 98 NORTH AMERICA: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 99 EUROPE: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 100 ASIA PACIFIC: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 101 LATIN AMERICA: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147 TABLE 102 MIDDLE EAST & AFRICA: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY REGION, 2022–2029 (USD MILLION) 147 TABLE 103 REFURBISHED SURGICAL DISPLAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 148 TABLE 104 NORTH AMERICA: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 105 EUROPE: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 106 ASIA PACIFIC: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 107 LATIN AMERICA: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 108 MIDDLE EAST & AFRICA: REFURBISHED SURGICAL DISPLAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 151 TABLE 109 OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 151 TABLE 110 NORTH AMERICA: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 111 EUROPE: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 112 ASIA PACIFIC: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029(USD MILLION) 153 TABLE 113 LATIN AMERICA: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153 TABLE 114 MIDDLE EAST & AFRICA: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 154 TABLE 115 REFURBISHED PATIENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 155 TABLE 116 REFURBISHED PATIENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 155 TABLE 117 NORTH AMERICA: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156 TABLE 118 EUROPE: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156 TABLE 119 ASIA PACIFIC: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157 TABLE 120 LATIN AMERICA: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157 TABLE 121 MIDDLE EAST & AFRICA: REFURBISHED PATIENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 158 TABLE 122 REFURBISHED PATIENT MONITORS MARKET, BY END USER, 2022–2029 (USD MILLION) 158 TABLE 123 REFURBISHED MULTIPARAMETER MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 159 TABLE 124 NORTH AMERICA: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160 TABLE 125 EUROPE: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160 TABLE 126 ASIA PACIFIC: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 127 LATIN AMERICA: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 128 MIDDLE EAST & AFRICA: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 162 TABLE 129 REFURBISHED FETAL MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 163 TABLE 130 NORTH AMERICA: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163 TABLE 131 EUROPE: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164 TABLE 132 ASIA PACIFIC: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164 TABLE 133 LATIN AMERICA: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165 TABLE 134 MIDDLE EAST & AFRICA: REFURBISHED FETAL MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 165 TABLE 135 REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 167 TABLE 136 NORTH AMERICA: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167 TABLE 137 EUROPE: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168 TABLE 138 ASIA PACIFIC: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168 TABLE 139 LATIN AMERICA: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169 TABLE 140 MIDDLE EAST & AFRICA: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 169 TABLE 141 REFURBISHED PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 170 TABLE 142 NORTH AMERICA: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171 TABLE 143 EUROPE: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171 TABLE 144 ASIA PACIFIC: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172 TABLE 145 LATIN AMERICA: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172 TABLE 146 MIDDLE EAST & AFRICA: REFURBISHED PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 173 TABLE 147 REFURBISHED CARDIAC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 174 TABLE 148 NORTH AMERICA: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174 TABLE 149 EUROPE: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175 TABLE 150 ASIA PACIFIC: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175 TABLE 151 LATIN AMERICA: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176 TABLE 152 MIDDLE EAST & AFRICA: REFURBISHED CARDIAC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 176 TABLE 153 REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 177 TABLE 154 NORTH AMERICA: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177 TABLE 155 EUROPE: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178 TABLE 156 ASIA PACIFIC: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178 TABLE 157 LATIN AMERICA: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179 TABLE 158 MIDDLE EAST & AFRICA: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 179 TABLE 159 OTHER REFURBISHED PATIENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 180 TABLE 160 NORTH AMERICA: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181 TABLE 161 EUROPE: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181 TABLE 162 ASIA PACIFIC: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182 TABLE 163 LATIN AMERICA: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182 TABLE 164 MIDDLE EAST & AFRICA: OTHER REFURBISHED PATIENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 183 TABLE 165 REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 183 TABLE 166 REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 184 TABLE 167 NORTH AMERICA: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184 TABLE 168 EUROPE: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185 TABLE 169 ASIA PACIFIC: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185 TABLE 170 LATIN AMERICA: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186 TABLE 171 MIDDLE EAST & AFRICA: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 186 TABLE 172 REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 187 TABLE 173 REFURBISHED DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 188 TABLE 174 NORTH AMERICA: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188 TABLE 175 EUROPE: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189 TABLE 176 ASIA PACIFIC: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189 TABLE 177 LATIN AMERICA: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190 TABLE 178 MIDDLE EAST & AFRICA: REFURBISHED DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 190 TABLE 179 REFURBISHED HEART-LUNG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 191 TABLE 180 NORTH AMERICA: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191 TABLE 181 EUROPE: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192 TABLE 182 ASIA PACIFIC: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192 TABLE 183 LATIN AMERICA: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193 TABLE 184 MIDDLE EAST & AFRICA: REFURBISHED HEART-LUNG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 193 TABLE 185 OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 194 TABLE 186 NORTH AMERICA: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194 TABLE 187 EUROPE: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195 TABLE 188 ASIA PACIFIC: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195 TABLE 189 LATIN AMERICA: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196 TABLE 190 MIDDLE EAST & AFRICA: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 196 TABLE 191 REFURBISHED UROLOGY EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 197 TABLE 192 REFURBISHED UROLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 197 TABLE 193 NORTH AMERICA: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 194 EUROPE: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 195 ASIA PACIFIC: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199 TABLE 196 LATIN AMERICA: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199 TABLE 197 MIDDLE EAST & AFRICA: REFURBISHED UROLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 200 TABLE 198 REFURBISHED UROLOGY EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 200 TABLE 199 REFURBISHED DIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 201 TABLE 200 NORTH AMERICA: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201 TABLE 201 EUROPE: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202 TABLE 202 ASIA PACIFIC: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202 TABLE 203 LATIN AMERICA: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 203 TABLE 204 MIDDLE EAST & AFRICA: REFURBISHED DIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 203 TABLE 205 REFURBISHED LITHOTRIPSY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 204 TABLE 206 NORTH AMERICA: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204 TABLE 207 EUROPE: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205 TABLE 208 ASIA PACIFIC: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205 TABLE 209 LATIN AMERICA: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206 TABLE 210 MIDDLE EAST & AFRICA: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 206 TABLE 211 REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 207 TABLE 212 REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 207 TABLE 213 NORTH AMERICA: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208 TABLE 214 EUROPE: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208 TABLE 215 ASIA PACIFIC: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209 TABLE 216 LATIN AMERICA: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209 TABLE 217 MIDDLE EAST & AFRICA: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 210 TABLE 218 REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 210 TABLE 219 REFURBISHED EMG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 211 TABLE 220 NORTH AMERICA: REFURBISHED EMG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211 TABLE 221 EUROPE: REFURBISHED EMG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212 TABLE 222 ASIA PACIFIC: REFURBISHED EMG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212 TABLE 223 LATIN AMERICA: REFURBISHED EMG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213 TABLE 224 MIDDLE EAST & AFRICA: REFURBISHED EMG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 213 TABLE 225 REFURBISHED EEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 214 TABLE 226 NORTH AMERICA: REFURBISHED EEG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214 TABLE 227 EUROPE: REFURBISHED EEG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215 TABLE 228 ASIA PACIFIC: REFURBISHED EEG MACHINES MARKET, BY COUNTRY, 2022–2029(USD MILLION) 215 TABLE 229 LATIN AMERICA: REFURBISHED EEG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216 TABLE 230 MIDDLE EAST & AFRICA: REFURBISHED EEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 216 TABLE 231 REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 217 TABLE 232 REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 217 TABLE 233 NORTH AMERICA: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218 TABLE 234 EUROPE: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218 TABLE 235 ASIA PACIFIC: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219 TABLE 236 LATIN AMERICA: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219 TABLE 237 MIDDLE EAST & AFRICA: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 220 TABLE 238 REFURBISHED MEDICAL EQUIPMENT MARKET FOR INTENSIVE CARE EQUIPMENT, BY END USER, 2022–2029 (USD MILLION) 220 TABLE 239 REFURBISHED VENTILATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 221 TABLE 240 NORTH AMERICA: REFURBISHED VENTILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222 TABLE 241 EUROPE: REFURBISHED VENTILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222 TABLE 242 ASIA PACIFIC: REFURBISHED VENTILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 243 LATIN AMERICA: REFURBISHED VENTILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 244 MIDDLE EAST & AFRICA: REFURBISHED VENTILATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 224 TABLE 245 REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY REGION, 2022–2029 (USD MILLION) 225 TABLE 246 NORTH AMERICA: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225 TABLE 247 EUROPE: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 226 TABLE 248 ASIA PACIFIC: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY COUNTRY, 2022–2029(USD MILLION) 226 TABLE 249 LATIN AMERICA: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 227 TABLE 250 MIDDLE EAST & AFRICA: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY REGION, 2022–2029 (USD MILLION) 227 TABLE 251 REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 229 TABLE 252 NORTH AMERICA: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 229 TABLE 253 EUROPE: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 230 TABLE 254 ASIA PACIFIC: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 230 TABLE 255 LATIN AMERICA: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 231 TABLE 256 MIDDLE EAST & AFRICA: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 231 TABLE 257 REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY END USER, 2022–2029 (USD MILLION) 232 TABLE 258 REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 233 TABLE 259 NORTH AMERICA: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 233 TABLE 260 EUROPE: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 261 ASIA PACIFIC: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 262 LATIN AMERICA: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 235 TABLE 263 MIDDLE EAST & AFRICA: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 235 TABLE 264 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ENDOSCOPY EQUIPMENT, BY END USER, 2022–2029 (USD MILLION) 236 TABLE 265 OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 237 TABLE 266 NORTH AMERICA: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 237 TABLE 267 EUROPE: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 238 TABLE 268 ASIA PACIFIC: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 238 TABLE 269 LATIN AMERICA: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 239 TABLE 270 MIDDLE EAST & AFRICA: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 239 TABLE 271 OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 240 TABLE 272 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 243 TABLE 273 REFURBISHED MEDICAL EQUIPMENT MARKET FOR CARDIOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 244 TABLE 274 REFURBISHED MEDICAL EQUIPMENT MARKET FOR UROLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 245 TABLE 275 REFURBISHED MEDICAL EQUIPMENT MARKET FOR NEUROLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 246 TABLE 276 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ORTHOPEDIC DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 247 TABLE 277 REFURBISHED MEDICAL EQUIPMENT MARKET FOR PHYSIOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 248 TABLE 278 REFURBISHED MEDICAL EQUIPMENT MARKET FOR EMERGENCY MEDICINE DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 249 TABLE 279 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ONCOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 250 TABLE 280 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OB/GYNECOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 251 TABLE 281 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 252 TABLE 282 REFURBISHED MEDICAL EQUIPMENT MARKET FOR CARDIOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 253 TABLE 283 REFURBISHED MEDICAL EQUIPMENT MARKET FOR UROLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 254 TABLE 284 REFURBISHED MEDICAL EQUIPMENT MARKET FOR NEUROLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 255 TABLE 285 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ORTHOPEDIC THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 256 TABLE 286 REFURBISHED MEDICAL EQUIPMENT MARKET FOR PHYSIOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 257 TABLE 287 REFURBISHED MEDICAL EQUIPMENT MARKET FOR EMERGENCY MEDICINE THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 258 TABLE 288 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ONCOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 259 TABLE 289 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OB/GYNECOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 260 TABLE 290 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 260 TABLE 291 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 262 TABLE 292 REFURBISHED MEDICAL EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION) 263 TABLE 293 REFURBISHED MEDICAL EQUIPMENT MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION) 264 TABLE 294 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ACADEMIC & GOVERNMENT ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION) 265 TABLE 295 REFURBISHED MEDICAL EQUIPMENT MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2022–2029 (USD MILLION) 266 TABLE 296 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 267 TABLE 297 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 269 TABLE 298 NORTH AMERICA: KEY MACROINDICATORS 270 TABLE 299 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 272 TABLE 300 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 272 TABLE 301 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 273 TABLE 302 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 274 TABLE 303 US: KEY MACROINDICATORS 275 TABLE 304 US: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 275 TABLE 305 CANADA: KEY MACROINDICATORS 276 TABLE 306 CANADA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 277 TABLE 307 EUROPE: KEY MACROINDICATORS 278 TABLE 308 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 279 TABLE 309 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 280 TABLE 310 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 281 TABLE 311 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 282 TABLE 312 GERMANY: KEY MACROINDICATORS 283 TABLE 313 GERMANY: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 283 TABLE 314 FRANCE: KEY MACROINDICATORS 284 TABLE 315 FRANCE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 285 TABLE 316 UK: KEY MACROINDICATORS 286 TABLE 317 UK: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 286 TABLE 318 ITALY: KEY MACROINDICATORS 287 TABLE 319 ITALY: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 288 TABLE 320 SPAIN: KEY MACROINDICATORS 289 TABLE 321 SPAIN: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 289 TABLE 322 REST OF EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 290 TABLE 323 ASIA PACIFIC: KEY MACROINDICATORS 292 TABLE 324 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 294 TABLE 325 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 295 TABLE 326 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 296 TABLE 327 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 297 TABLE 328 CHINA: KEY MACROINDICATORS 298 TABLE 329 CHINA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 298 TABLE 330 JAPAN: KEY MACROINDICATORS 299 TABLE 331 JAPAN: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 300 TABLE 332 INDIA: KEY MACROINDICATORS 301 TABLE 333 INDIA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 301 TABLE 334 AUSTRALIA: KEY MACROINDICATORS 302 TABLE 335 AUSTRALIA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 303 TABLE 336 SOUTH KOREA: KEY MACROINDICATORS 304 TABLE 337 SOUTH KOREA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 304 TABLE 338 REST OF ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 305 TABLE 339 LATIN AMERICA: KEY MACROINDICATORS 306 TABLE 340 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 306 TABLE 341 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 307 TABLE 342 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 308 TABLE 343 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 309 TABLE 344 BRAZIL: KEY MACROINDICATORS 310 TABLE 345 BRAZIL: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 310 TABLE 346 MEXICO: KEY MACROINDICATORS 311 TABLE 347 MEXICO: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 312 TABLE 348 REST OF LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 313 TABLE 349 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 314 TABLE 350 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 315 TABLE 351 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 315 TABLE 352 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 316 TABLE 353 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 317 TABLE 354 GCC COUNTRIES: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 318 TABLE 355 REST OF MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 319 TABLE 356 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN REFURBISHED MEDICAL EQUIPMENT MARKET 320 TABLE 357 REFURBISHED MEDICAL EQUIPMENT MARKET: DEGREE OF COMPETITION 325 TABLE 358 REFURBISHED MEDICAL EQUIPMENT MARKET: REGION FOOTPRINT 329 TABLE 359 REFURBISHED MEDICAL EQUIPMENT MARKET: PRODUCT FOOTPRINT 330 TABLE 360 REFURBISHED MEDICAL EQUIPMENT MARKET: APPLICATION FOOTPRINT 331 TABLE 361 REFURBISHED MEDICAL EQUIPMENT MARKET: END-USER FOOTPRINT 332 TABLE 362 REFURBISHED MEDICAL EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 335 TABLE 363 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 336 TABLE 364 REFURBISHED MEDICAL EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 339 TABLE 365 REFURBISHED MEDICAL EQUIPMENT MARKET: DEALS, JANUARY 2021– NOVEMBER 2024 340 TABLE 366 GE HEALTHCARE: COMPANY OVERVIEW 341 TABLE 367 GE HEALTHCARE: PRODUCTS OFFERED 343 TABLE 368 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 345 TABLE 369 GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 345 TABLE 370 GE HEALTHCARE: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 345 TABLE 371 PHILIPS HEALTHCARE: COMPANY OVERVIEW 347 TABLE 372 PHILIPS HEALTHCARE: PRODUCTS OFFERED 348 TABLE 373 PHILIPS HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 350 TABLE 374 PHILIPS HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 351 TABLE 375 PHILIPS HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 351 TABLE 376 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 353 TABLE 377 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 354 TABLE 378 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024 356 TABLE 379 STRYKER: COMPANY OVERVIEW 357 TABLE 380 STRYKER: PRODUCTS OFFERED 358 TABLE 381 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 360 TABLE 382 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 361 TABLE 383 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 361 TABLE 384 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 363 TABLE 385 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 365 TABLE 386 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 365 TABLE 387 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 365 TABLE 388 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 366 TABLE 389 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 367 TABLE 390 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 368 TABLE 391 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 369 TABLE 392 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 370 TABLE 393 OLYMPUS CORPORATION.: COMPANY OVERVIEW 371 TABLE 394 OLYMPUS CORPORATION: PRODUCTS OFFERED 373 TABLE 395 AVANTE HEALTH SOLUTIONS: COMPANY OVERVIEW 374 TABLE 396 AVANTE HEALTH SOLUTIONS: PRODUCTS OFFERED 375 TABLE 397 SOMA TECH INTL.: COMPANY OVERVIEW 376 TABLE 398 SOMA TECH INTL.: PRODUCTS OFFERED 376 TABLE 399 EVERX: COMPANY OVERVIEW 378 TABLE 400 EVERX: PRODUCTS OFFERED 378 TABLE 401 RADIOLOGY ONCOLOGY SYSTEMS: COMPANY OVERVIEW 379 TABLE 402 RADIOLOGY ONCOLOGY SYSTEMS: PRODUCTS OFFERED 379 TABLE 403 RADIOLOGY ONCOLOGY SYSTEMS: DEALS, JANUARY 2021–NOVEMBER 2024 380 TABLE 404 MASTER MEDICAL EQUIPMENT: COMPANY OVERVIEW 381 TABLE 405 MASTER MEDICAL EQUIPMENT: PRODUCTS OFFERED 381 TABLE 406 FAIR-MEDICAL INC.: COMPANY OVERVIEW 382 TABLE 407 FAIR-MEDICAL INC.: PRODUCTS OFFERED 382 TABLE 408 FUTURE HEALTH CONCEPTS: COMPANY OVERVIEW 383 TABLE 409 FUTURE HEALTH CONCEPTS: PRODUCTS OFFERED 383 TABLE 410 HILDITCH GROUP LTD.: COMPANY OVERVIEW 384 TABLE 411 HILDITCH GROUP LTD.: PRODUCTS OFFERED 385 TABLE 412 BLOCK IMAGING, INC.: COMPANY OVERVIEW 386 TABLE 413 BLOCK IMAGING, INC.: PRODUCTS OFFERED 386 TABLE 414 BLOCK IMAGING, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 387 TABLE 415 NATIONWIDE IMAGING SERVICES: COMPANY OVERVIEW 388 TABLE 416 PACIFIC HEALTHCARE IMAGING: COMPANY OVERVIEW 389 TABLE 417 VENTURE MEDICAL REQUIP: COMPANY OVERVIEW 390 TABLE 418 DESERT TECH MEDICAL SYSTEMS INC.: COMPANY OVERVIEW 391 TABLE 419 HI-TECH INTERNATIONAL: COMPANY OVERVIEW 392 TABLE 420 AMBER DIAGNOSTICS: COMPANY OVERVIEW 393 TABLE 421 WHITTEMORE ENTERPRISES: COMPANY OVERVIEW 394 TABLE 422 TRACO MEDICAL INC.: COMPANY OVERVIEW 395 TABLE 423 US MED-EQUIP: COMPANY OVERVIEW 396 TABLE 424 US MEDICAL SYSTEMS: COMPANY OVERVIEW 397 TABLE 425 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW 398 TABLE 426 DIRECTMED IMAGING: COMPANY OVERVIEW 399 TABLE 427 AGITO MEDICAL: COMPANY OVERVIEW 400 FIGURE 1 REFURBISHED MEDICAL EQUIPMENT MARKET: SEGMENTS COVERED & GEOGRAPHICAL SPREAD 35 FIGURE 2 REFURBISHED MEDICAL EQUIPMENT MARKET: YEARS CONSIDERED 37 FIGURE 3 REFURBISHED MEDICAL EQUIPMENT MARKET: RESEARCH DATA 39 FIGURE 4 REFURBISHED MEDICAL EQUIPMENT MARKET: RESEARCH DESIGN 40 FIGURE 5 REFURBISHED MEDICAL EQUIPMENT MARKET: KEY DATA FROM SECONDARY SOURCES 42 FIGURE 6 REFURBISHED MEDICAL EQUIPMENT MARKET: KEY PRIMARY SOURCES 43 FIGURE 7 REFURBISHED MEDICAL EQUIPMENT MARKET: KEY INDUSTRY INSIGHTS 44 FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 44 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45 FIGURE 10 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 46 FIGURE 11 REFURBISHED MEDICAL EQUIPMENT MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 47 FIGURE 12 REFURBISHED MEDICAL EQUIPMENT MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 48 FIGURE 13 REFURBISHED MEDICAL EQUIPMENT MARKET: TOP-DOWN APPROACH 48 FIGURE 14 REFURBISHED MEDICAL EQUIPMENT MARKET: DATA TRIANGULATION 50 FIGURE 15 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 52 FIGURE 16 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 56 FIGURE 17 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 57 FIGURE 18 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 58 FIGURE 19 REGIONAL SNAPSHOT OF REFURBISHED MEDICAL EQUIPMENT MARKET 59 FIGURE 20 INCREASING DEMAND FOR ADVANCED REFURBISHED MEDICAL EQUIPMENT TO DRIVE MARKET 60 FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61 FIGURE 22 US AND ACADEMIC & GOVERNMENT ORGANIZATIONS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 62 FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029 63 FIGURE 24 REFURBISHED MEDICAL EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64 FIGURE 25 REFURBISHED MEDICAL EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 71 FIGURE 26 REFURBISHED MEDICAL EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 72 FIGURE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 74 FIGURE 28 KEY BUYING CRITERIA FOR TOP FOUR END USERS 75 FIGURE 29 PATENT ANALYSIS FOR REFURBISHED MEDICAL EQUIPMENT (JANUARY 2014–AUGUST 2024) 76 FIGURE 30 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL IMAGING EQUIPMENT, BY PRODUCT, 2021–2023 (USD) 85 FIGURE 31 AVERAGE SELLING PRICE TREND OF REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT, BY PRODUCT, 2021–2023 (USD) 86 FIGURE 32 AVERAGE SELLING PRICE TREND OF REFURBISHED PATIENT MONITORS, BY PRODUCT, 2021–2023 (USD) 86 FIGURE 33 AVERAGE SELLING PRICE TREND OF OTHER REFURBISHED MEDICAL EQUIPMENT, BY PRODUCT, 2021–2023 (USD) 87 FIGURE 34 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT, BY KEY PLAYER, 2023 (USD) 88 FIGURE 35 REFURBISHED MEDICAL EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 90 FIGURE 36 REFURBISHED MEDICAL EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 92 FIGURE 37 REFURBISHED MEDICAL EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93 FIGURE 38 REFURBISHED MEDICAL EQUIPMENT MARKET: INVESTMENT & FUNDING SCENARIO, 2019–2023 102 FIGURE 39 REFURBISHED MEDICAL EQUIPMENT MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 103 FIGURE 40 REFURBISHED MEDICAL EQUIPMENT MARKET: DEAL VALUE, BY KEY PLAYER, 2019–2023 (USD MILLION) 103 FIGURE 41 REFURBISHED MEDICAL EQUIPMENT MARKET: IMPACT OF AI/GEN AI 105 FIGURE 42 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET SNAPSHOT 271 FIGURE 43 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET SNAPSHOT 293 FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN REFURBISHED MEDICAL EQUIPMENT MARKET (2019–2023) 322 FIGURE 45 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET SHARE (2023) 323 FIGURE 46 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET SHARE (2023) 323 FIGURE 47 REFURBISHED PATIENT MONITORS MARKET SHARE (2023) 324 FIGURE 48 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 327 FIGURE 49 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPANY FOOTPRINT 328 FIGURE 50 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 334 FIGURE 51 EV/EBITDA OF KEY VENDORS 337 FIGURE 52 5-YEAR STOCK BETA OF KEY VENDORS 337 FIGURE 53 REFURBISHED MEDICAL EQUIPMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 338 FIGURE 54 GE HEALTHCARE: COMPANY SNAPSHOT 342 FIGURE 55 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 348 FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 354 FIGURE 57 STRYKER: COMPANY SNAPSHOT 358 FIGURE 58 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 360 FIGURE 59 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 364 FIGURE 60 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT 367 FIGURE 61 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 369 FIGURE 62 OLYMPUS CORPORATION: COMPANY SNAPSHOT 372

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們